AU Stock MarketDetailed Quotes

CYPOA Cynata Therapeutics Ltd

Watchlist
  • 0.030
  • -0.010-25.00%
20min DelayMarket Closed Nov 15 14:26 AET
5.42MMarket Cap0.00P/E (Static)

Cynata Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Jun 30, 2018
Total revenue
Cost of revenue
Gross profit
Operating expense
-24.16%12.55M
19.54%16.54M
52.39%13.84M
-13.62%9.08M
4.49%10.51M
64.10%10.06M
6.13M
Selling and administrative expenses
-0.83%3.21M
-20.39%3.23M
-9.65%4.06M
52.87%4.49M
-8.60%2.94M
31.05%3.22M
--2.45M
-Selling and marketing expense
43.11%80.67K
-14.55%56.37K
-75.54%65.97K
-42.96%269.65K
-18.68%472.74K
--581.35K
----
-General and administrative expense
-1.61%3.12M
-20.49%3.18M
-5.44%3.99M
71.24%4.22M
-6.37%2.47M
7.36%2.63M
--2.45M
Research and development costs
-29.96%8.68M
40.45%12.39M
133.58%8.82M
--3.78M
----
----
----
Depreciation amortization depletion
0.27%280.73K
0.00%279.97K
0.00%279.97K
-0.27%279.97K
0.27%280.73K
0.00%279.97K
--279.97K
-Depreciation and amortization
0.27%280.73K
0.00%279.97K
0.00%279.97K
-0.27%279.97K
0.27%280.73K
0.00%279.97K
--279.97K
Other operating expenses
-40.54%378.18K
-5.49%636.07K
27.34%672.99K
-92.75%528.51K
11.08%7.29M
93.27%6.56M
--3.4M
Operating profit
24.16%-12.55M
-19.54%-16.54M
-52.39%-13.84M
13.62%-9.08M
-4.49%-10.51M
-64.10%-10.06M
-6.13M
Net non-operating interest income (expenses)
18.38%417.71K
444.98%352.87K
-29.85%64.75K
-35.16%92.3K
-45.37%142.35K
82.30%260.55K
142.93K
Non-operating interest income
18.38%417.71K
444.98%352.87K
-29.85%64.75K
-35.16%92.3K
-45.37%142.35K
82.30%260.55K
--142.93K
Other net income (expenses)
24.64%2.38M
-77.04%1.91M
541.41%8.33M
-80.71%1.3M
406.69%6.73M
-6.58%1.33M
1.42M
Other non-operating income (expenses)
24.64%2.38M
-77.04%1.91M
541.41%8.33M
-80.71%1.3M
406.69%6.73M
-6.58%1.33M
--1.42M
Income before tax
31.75%-9.74M
-162.20%-14.28M
29.19%-5.45M
-111.31%-7.69M
57.05%-3.64M
-85.54%-8.47M
-4.57M
Income tax
0
0
0
0
0
0
0
Earnings from equity interest net of tax
Net income
31.75%-9.74M
-162.20%-14.28M
29.19%-5.45M
-111.31%-7.69M
57.05%-3.64M
-85.54%-8.47M
-4.57M
Net income continuous operations
31.75%-9.74M
-162.20%-14.28M
29.19%-5.45M
-111.31%-7.69M
57.05%-3.64M
-85.54%-8.47M
---4.57M
Noncontrolling interests
Net income attributable to the company
31.75%-9.74M
-162.20%-14.28M
29.19%-5.45M
-111.31%-7.69M
57.05%-3.64M
-85.54%-8.47M
-4.57M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
31.75%-9.74M
-162.20%-14.28M
29.19%-5.45M
-111.31%-7.69M
57.05%-3.64M
-85.54%-8.47M
-4.57M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Jun 30, 2018
Total revenue
Cost of revenue
Gross profit
Operating expense -24.16%12.55M19.54%16.54M52.39%13.84M-13.62%9.08M4.49%10.51M64.10%10.06M6.13M
Selling and administrative expenses -0.83%3.21M-20.39%3.23M-9.65%4.06M52.87%4.49M-8.60%2.94M31.05%3.22M--2.45M
-Selling and marketing expense 43.11%80.67K-14.55%56.37K-75.54%65.97K-42.96%269.65K-18.68%472.74K--581.35K----
-General and administrative expense -1.61%3.12M-20.49%3.18M-5.44%3.99M71.24%4.22M-6.37%2.47M7.36%2.63M--2.45M
Research and development costs -29.96%8.68M40.45%12.39M133.58%8.82M--3.78M------------
Depreciation amortization depletion 0.27%280.73K0.00%279.97K0.00%279.97K-0.27%279.97K0.27%280.73K0.00%279.97K--279.97K
-Depreciation and amortization 0.27%280.73K0.00%279.97K0.00%279.97K-0.27%279.97K0.27%280.73K0.00%279.97K--279.97K
Other operating expenses -40.54%378.18K-5.49%636.07K27.34%672.99K-92.75%528.51K11.08%7.29M93.27%6.56M--3.4M
Operating profit 24.16%-12.55M-19.54%-16.54M-52.39%-13.84M13.62%-9.08M-4.49%-10.51M-64.10%-10.06M-6.13M
Net non-operating interest income (expenses) 18.38%417.71K444.98%352.87K-29.85%64.75K-35.16%92.3K-45.37%142.35K82.30%260.55K142.93K
Non-operating interest income 18.38%417.71K444.98%352.87K-29.85%64.75K-35.16%92.3K-45.37%142.35K82.30%260.55K--142.93K
Other net income (expenses) 24.64%2.38M-77.04%1.91M541.41%8.33M-80.71%1.3M406.69%6.73M-6.58%1.33M1.42M
Other non-operating income (expenses) 24.64%2.38M-77.04%1.91M541.41%8.33M-80.71%1.3M406.69%6.73M-6.58%1.33M--1.42M
Income before tax 31.75%-9.74M-162.20%-14.28M29.19%-5.45M-111.31%-7.69M57.05%-3.64M-85.54%-8.47M-4.57M
Income tax 0000000
Earnings from equity interest net of tax
Net income 31.75%-9.74M-162.20%-14.28M29.19%-5.45M-111.31%-7.69M57.05%-3.64M-85.54%-8.47M-4.57M
Net income continuous operations 31.75%-9.74M-162.20%-14.28M29.19%-5.45M-111.31%-7.69M57.05%-3.64M-85.54%-8.47M---4.57M
Noncontrolling interests
Net income attributable to the company 31.75%-9.74M-162.20%-14.28M29.19%-5.45M-111.31%-7.69M57.05%-3.64M-85.54%-8.47M-4.57M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 31.75%-9.74M-162.20%-14.28M29.19%-5.45M-111.31%-7.69M57.05%-3.64M-85.54%-8.47M-4.57M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data